Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Topical Diclofenac and Topical DFMO Chemoprevention Trial in Subjects with a History of Skin Cancer

Research Group
Prostate and Urologic Cancer
Sponsor
University of Alabama at Birmingham
Status
Active, not recruiting
NCT ID
NCT04091022
This is a single institution, randomized, placebo-controlled, double-blind phase IIB trial of 1) topical diclofenac and topical DFMO, or 2) placebo in participants with a history of non melanoma skin cancer/ keratinocytic cancers.
Intervention
Solaraze and Vaniqa
Condition
Non-melanoma Skin Cancer
Investigators
Craug Elmets, MD

See list of participating sites